Symbols / EVOK
EVOK Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2025-11-13 07:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Why The Narrative Around Evoke (LSE:EVOK) Is Shifting With Higher UK Gaming Taxes - Yahoo Finance Mon, 23 Feb 2026 23
- EVOK Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Evoke Pharma, Inc. is Fair to Shareholders - Business Wire ue, 04 Nov 2025 08
- Evoke (LON:EVOK) Trading Down 2.7% - Time to Sell? - MarketBeat Fri, 20 Feb 2026 11
- Evoke Pharma (NASDAQ: EVOK) to be acquired for $11.00/share; tender offer, closing in 2025 - Stock Titan ue, 04 Nov 2025 08
- EVOK Stock Doubled In Value Today Post QOL Medical Deal, But Still Fails To Hit $11 Mark - Stocktwits ue, 04 Nov 2025 08
- How Low Can Evoke Pharma Stock Really Go? - Trefis Sun, 21 Dec 2025 08
- Evoke Pharma stock soars after QOL Medical acquisition announcement - Investing.com ue, 04 Nov 2025 08
- Investors Still Aren't Entirely Convinced By Evoke Pharma, Inc.'s (NASDAQ:EVOK) Revenues Despite 31% Price Jump - simplywall.st ue, 19 Aug 2025 07
- Evoke Pharma Acquired by QOL Medical, Nasdaq Trading Ends - TipRanks Wed, 17 Dec 2025 08
- Major Pharmacy Network Expansion: Evoke's GIMOTI Now Reaching 150+ GI Practice Locations via Omnicell Deal - Stock Titan ue, 26 Aug 2025 07
- Evoke Pharma, Inc. (NASDAQ:EVOK) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance Sun, 17 Aug 2025 07
- Evoke (LON:EVOK) Shares Up 10% - Here's Why - MarketBeat hu, 22 Jan 2026 08
- QOL Medical to acquire Evoke Pharma for $11 per share in cash deal - Investing.com ue, 04 Nov 2025 08
- Analysts Expect Breakeven For Evoke Pharma, Inc. (NASDAQ:EVOK) Before Long - simplywall.st ue, 28 Oct 2025 07
- Evoke Pharma investors get $11 a share as the company leaves Nasdaq - Stock Titan Wed, 17 Dec 2025 08
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for EVOK
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|